You have 9 free searches left this month | for more free features.

Immunomodulation

Showing 1 - 25 of 451

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Traumatic Brain Injury Trial (Mesenchymal Stromal Cells (MSC), )

Not yet recruiting
  • Traumatic Brain Injury
  • Mesenchymal Stromal Cells (MSC)
  • placebo
  • (no location specified)
Nov 17, 2023

Upper Respiratory Tract Infection (URTI) Trial (Placebo, Verum)

Not yet recruiting
  • Upper Respiratory Tract Infection (URTI)
  • Placebo
  • Verum
  • (no location specified)
Nov 2, 2022

Inflammation, HIV Infection, Cardiovascular Disease Trial in San Francisco (VB-201, Placebo)

Withdrawn
  • Inflammation
  • +2 more
  • San Francisco, California
    Zuckerberg San Francisco General Hospital
Sep 12, 2022

Hepatopancreaticobiliary (HPB) Malignancy, Surgery Trial in Ottawa, Toronto (Active A, Active B, Lipid bolus)

Recruiting
  • Hepatopancreaticobiliary (HPB) Malignancy
  • Surgery
  • Active A
  • +3 more
  • Ottawa, Ontario, Canada
  • +1 more
Jun 6, 2022

Brittle Type 1 Diabetes Trial (AT-1501 IV Infusion, Isolated cadaveric islet cells)

Not yet recruiting
  • Brittle Type 1 Diabetes Mellitus
  • AT-1501 IV Infusion
  • Isolated cadaveric islet cells
  • (no location specified)
Jul 27, 2022

Analgesia, Breast Cancer Trial in Alexandria (Erector Spinae Plane Block with Bubivacaine, Standard General Anaesthesia)

Completed
  • Analgesia
  • Breast Cancer
  • Erector Spinae Plane Block with Bubivacaine
  • Standard General Anaesthesia
  • Alexandria, Egypt
    Medical Research Institute, Alexandria University
Apr 3, 2022

Immunosuppression Trial in Durham (Belatacept, Hand transplant)

Recruiting
  • Immunosuppression
  • Durham, North Carolina
    Duke University Medical Center
Jan 18, 2022

Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Eltrombopag (Revolade®)
  • standard therapy (without eltrombopag): HD-DXM
  • Aarau, Switzerland
  • +5 more
Sep 5, 2022

Immunomodulation in Hidradenitis Suppurativa and Evaluation

Not yet recruiting
  • Hidradenitis Suppurativa
  • Blood tests
  • +2 more
  • Lille, France
  • +1 more
Apr 4, 2022

Spinal Cord Injuries, Urinary Tract Infections Trial in Nottwil (Uro-Vaxom, Placebo oral tablet)

Recruiting
  • Spinal Cord Injuries
  • Urinary Tract Infections
  • Nottwil, LU, Switzerland
    Swiss Paraplegic Centre
Jan 26, 2022

COVID-19, Acute Respiratory Distress Syndrome, Severe Acute Respiratory Syndrome (SARS) Trial in Royal Oak (Naltrexone,

Terminated
  • COVID-19
  • +3 more
  • Royal Oak, Michigan
    William Beaumont Hospital
Jan 12, 2022

Heart Transplant, Immunosuppression, Allograft Trial (HeartCare)

Not yet recruiting
  • Heart Transplant
  • +2 more
  • HeartCare
  • (no location specified)
Jul 12, 2022

Extramembranous Glomerulopathy Trial in Nice (Blood sample)

Recruiting
  • Extramembranous Glomerulopathy
  • Blood sample
  • Nice, France
    Centre Hospitalier Universitaire de Nice
Jun 20, 2022

Immunomodulation Trial in Gdansk (Nutridrink Skin Repair with a mixture of plant extracts rich in polyphenolic compounds,

Not yet recruiting
  • Immunomodulation
  • Nutridrink Skin Repair with a mixture of plant extracts rich in polyphenolic compounds
  • Nutridrink Skin Repair
  • Gdańsk, Poland
    Uniwersyteckie Centrum Kliniczne, Klinika Chirurgii Onkologiczne
Aug 24, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

COVID-19 Trial in Budapest (Extracorporeal photopheresis)

Recruiting
  • COVID-19
  • Extracorporeal photopheresis
  • Budapest, Hungary
    South Pest Central Hospital, National Institute of Haematology a
May 28, 2023

Type 1 Diabetes Trial in Edmonton (AT-1501)

Recruiting
  • Type 1 Diabetes Mellitus
  • Edmonton, Alberta, Canada
    University of Alberta
Sep 2, 2021

Systemic Lupus Erythematosus Trial run by the NIAMS (PET/CT, Pioglitazone, Placebo)

Completed
  • Systemic Lupus Erythematosus
  • PET/CT
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 23, 2021

Critical Injury (Trauma) in Children Trial in United States (GM-CSF)

Completed
  • Critical Injury (Trauma) in Children
  • Aurora, Colorado
  • +7 more
Feb 24, 2022

Amputation, Traumatic, Amputation;Traumatic;Old, Face Injury Trial in Boston (IL-2)

Terminated
  • Amputation, Traumatic
  • +4 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 22, 2021

Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With

Recruiting
  • Tumor Cell, Circulating
  • Adjuvant radiotherapy
  • neoadjuvant and adjuvant chemotherapy
  • Jena, Germany
    Department of Radiooncology, Jena
Sep 28, 2021

Covid19, Cytokine Storm, Inflammation Trial in Saint Paul (Splenic ultrasound)

Completed
  • Covid19
  • +2 more
  • Splenic ultrasound
  • Saint Paul, Minnesota
    M Health Fairview St. Joseph's Hospital
Aug 5, 2022

Systemic Inflammatory Response Syndrome, Postoperative Pain, Acute, Postoperative Pain, Chronic Trial in Heraklion (Opioid-Based

Recruiting
  • Systemic Inflammatory Response Syndrome
  • +6 more
  • Opioid-Based Anesthesia-Analgesia Strategy
  • Opioid-free Anesthesia-Analgesia Strategy
  • Heraklion, Crete, Greece
    University of Crete
Dec 10, 2021

Immune System Tolerance, Depression, Obesity Trial in Graz (Aronia Juice, Placebo)

Recruiting
  • Immune System Tolerance
  • +4 more
  • Aronia Juice
  • Placebo
  • Graz, Styria, Austria
    Medical Universtiy of Graz
Jun 20, 2022

Unresectable Colorectal Liver Metastases Trial in Boulogne-Billancourt (Chemotherapy, Radiofrequency ablation (RFA), In situ

Not yet recruiting
  • Unresectable Colorectal Liver Metastases
  • Boulogne-Billancourt, France
    Digestive Surgery Department, Ambroise Pare University Hospital,
Jun 14, 2021